Repositorio Institucional
Repositorio Institucional
CONICET Digital
  • Inicio
  • EXPLORAR
    • AUTORES
    • DISCIPLINAS
    • COMUNIDADES
  • Estadísticas
  • Novedades
    • Noticias
    • Boletines
  • Ayuda
    • General
    • Datos de investigación
  • Acerca de
    • CONICET Digital
    • Equipo
    • Red Federal
  • Contacto
JavaScript is disabled for your browser. Some features of this site may not work without it.
  • INFORMACIÓN GENERAL
  • RESUMEN
  • ESTADISTICAS
 
Artículo

Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic

Otero-losada, Matilde EstelaIcon ; Kobiec, TamaraIcon ; Udovin, LucasIcon ; Chevalier, GuensonIcon ; Quarracino, CeciliaIcon ; Menéndez Maissonave, Camila Belen; Bordet, SofíaIcon ; Capani, FranciscoIcon ; Perez Lloret, SantiagoIcon
Fecha de publicación: 08/2020
Editorial: Frontiers
Revista: Frontiers in neurology
ISSN: 1664-2295
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:
Neurociencias

Resumen

Humankind has gone through major airborne virus pandemics in the modern era. Coronavirus outbreaks have been registered in 2003 [severe acute respiratory syndrome (SARS)], 2009 [Middle East respiratory syndrome (MERS)], and 2019/2020 ongoing [CoV disease (COVID-19)]. Influenza outbreaks were documented in 1918 (post-World War I Spanish flu, H1N1 virus), 1957–1958 (Asian flu, H2N2 virus), 1968 (the Hong Kong flu, H3N2 virus), and 2009 (the swine flu, H1N1 virus). These viruses can only affect humans after mutating in their usual animal hosts, presenting as a zoonotic disease in the beginning. Unknown to the human immune system, they spread swiftly, resulting in outbreaks. Fatality rates vary from >30% for MERS, ~10% for the 1918 Spanish flu, 10% for SARS to <1% for the 2009 MERS. The number of infected people was 700 or 500 million with 2009's or 1918's H1N1 virus, respectively, 8,000 with SARS-CoV-1, and 2,500 with MERS-CoV. As of June 29th, according to the World Health Organization's daily situation report no. 161, SARS-CoV-2 has infected 10 million people, with a 4.98% case fatality rate.
Palabras clave: CORONAVIRUS , COVID-19 , INFLUENAZA VIRUS , NEUROLOGICAL DISEASES , NEUROLOGICAL IMPACT , PARKINSON'S DISEASE , SARS-COV-2 , VIRAL INFECTION
Ver el registro completo
 
Archivos asociados
Thumbnail
 
Tamaño: 521.3Kb
Formato: PDF
.
Descargar
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/115618
DOI: http://dx.doi.org/10.3389/fneur.2020.00995
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516057/
URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00995/full
Colecciones
Articulos(SEDE CENTRAL)
Articulos de SEDE CENTRAL
Citación
Otero-losada, Matilde Estela; Kobiec, Tamara; Udovin, Lucas; Chevalier, Guenson; Quarracino, Cecilia; et al.; Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic; Frontiers; Frontiers in neurology; 8-2020
Compartir
Altmétricas
 

Enviar por e-mail
Separar cada destinatario (hasta 5) con punto y coma.
  • Facebook
  • X Conicet Digital
  • Instagram
  • YouTube
  • Sound Cloud
  • LinkedIn

Los contenidos del CONICET están licenciados bajo Creative Commons Reconocimiento 2.5 Argentina License

https://www.conicet.gov.ar/ - CONICET

Inicio

Explorar

  • Autores
  • Disciplinas
  • Comunidades

Estadísticas

Novedades

  • Noticias
  • Boletines

Ayuda

Acerca de

  • CONICET Digital
  • Equipo
  • Red Federal

Contacto

Godoy Cruz 2290 (C1425FQB) CABA – República Argentina – Tel: +5411 4899-5400 repositorio@conicet.gov.ar
TÉRMINOS Y CONDICIONES